NASDAQ:YMTX

Yumanity Therapeutics (YMTX) Stock Price, News & Analysis

$0.62
-0.05 (-7.46%)
(As of 04/24/2024 ET)
Today's Range
$0.60
$0.67
50-Day Range
$0.34
$2.83
52-Week Range
$0.95
$13.23
Volume
172,143 shs
Average Volume
473,083 shs
Market Capitalization
$6.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
YMTX stock logo

About Yumanity Therapeutics Stock (NASDAQ:YMTX)

Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein. The company is also developing YTX-9184, which is in preclinical studies to treat neurological disorders. Yumanity Therapeutics Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

YMTX Stock Price History

YMTX Stock News Headlines

Yumanity Therapeutics (NASDAQ:YMTX) Stock Price Up 20.5%
JSPR Jasper Therapeutics, Inc.
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Cara Therapeutics Inc CARA
Yumanity Therapeutics Inc.
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Why Is Yumanity Therapeutics (YMTX) Stock Up Today?
See More Headlines
Receive YMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2021
Today
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:YMTX
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$-39,500,000.00
Net Margins
-660.61%
Pretax Margin
-660.61%

Debt

Sales & Book Value

Annual Sales
$4.84 million
Book Value
$2.28 per share

Miscellaneous

Free Float
9,504,000
Market Cap
$6.73 million
Optionable
Not Optionable
Beta
0.32
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Dr. Richard Peters M.D. (Age 59)
    Ph.D., CEO, Pres & Director
    Comp: $896.1k
  • Dr. Vikram Khurana M.D.
    Ph.D., Scientific Co-Founder & Sr. Advisor of Discovery Biology
  • Ms. Chee Yeun Chung Ph.D.
    Scientific Co-Founder & Associate Director of Discovery Biology
  • Ms. Marie Epstein CPA
    VP of Fin.
  • Mr. Michael D. Wyzga (Age 33)
    SVP, CFO & Treasurer
  • Mr. Devin Whittemore Smith (Age 54)
    SVP, Gen. Counsel & Sec.

YMTX Stock Analysis - Frequently Asked Questions

How have YMTX shares performed in 2024?

Yumanity Therapeutics' stock was trading at $3.63 at the beginning of the year. Since then, YMTX stock has decreased by 82.9% and is now trading at $0.62.
View the best growth stocks for 2024 here
.

How were Yumanity Therapeutics' earnings last quarter?

Yumanity Therapeutics, Inc. (NASDAQ:YMTX) posted its earnings results on Thursday, August, 12th. The company reported ($1.03) EPS for the quarter, missing the consensus estimate of ($0.84) by $0.19. The firm earned $2.11 million during the quarter, compared to the consensus estimate of $2.27 million. Yumanity Therapeutics had a negative trailing twelve-month return on equity of 263.34% and a negative net margin of 660.61%.

How do I buy shares of Yumanity Therapeutics?

Shares of YMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:YMTX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners